Home › Funds › B Group, Inc. › CLLS

B Group, Inc. position in CLLS

CELLECTIS S A · Health Care

B Group, Inc. reported holding 3,281,501 shares of CLLS (CELLECTIS S A) in its Q3 2026 13F filing — a position valued at US$5.0M, representing 3.06% of its reported portfolio and ranking #12 among its reported holdings. B Group, Inc. has disclosed CLLS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)3.28M sh
Reported value held$4.96M
Portfolio Weight3.06%
First reportedQ4 2024
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How B Group, Inc.'s CLLS position evolved

B Group, Inc. first disclosed a stake in CLLS in Q4 2024 at 3,081,501 shares (US$5.5M). The position peaked in Q4 2025 at 3,281,501 shares, worth US$15.9M. Across 8 filings, B Group, Inc. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 3,281,501 shares valued at US$5.0M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 3.08M $5.55M New
Q1 2025 3.26M $4.04M Add
Q2 2025 3.26M $4.97M Hold
Q3 2025 3.28M $9.35M Add
Q4 2025 3.28M $15.88M Hold
Q1 2026 3.28M $10.40M Hold
Q2 2026 3.28M $9.84M Hold
Q3 2026 3.28M $4.96M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLLS and 13F data

CLLS (CELLECTIS S A) is a Health Care company. 18 other funds we track also report a position in CLLS. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLLS

No other tracked fund reports a position in CLLS.

All CLLS fund holders →

FAQ

How long has B Group, Inc. held CLLS?

B Group, Inc. has disclosed CLLS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is B Group, Inc.'s current position in CLLS?

As of Q3 2026, B Group, Inc. holds 3.28M shares of CLLS (CELLECTIS S A), valued at $4.96M, representing 3.06% of its reported portfolio and ranking #12.

Has B Group, Inc. been buying or selling CLLS?

In the latest 13F filing (Q3 2026), B Group, Inc. held unchanged its position in CLLS. The position peaked in Q4 2025 at 3.28M shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.